Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology, and Child Health
Reference56 articles.
1. Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee H-J, Eldred A, Dufek MB (2017) Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol. doi:
10.1007/s00467-017-3579-6
2. National Kidney Foundation (2005) K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46[4 Suppl 1]:S1–103
3. Bertram JF, Goldstein SL, Pape L, Schaefer F, Shroff RC, Warady BA (2016) Kidney disease in children: latest advances and remaining challenges. Nat Rev Nephrol 12:182–191
4. Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370–1378 Erratum in: Kidney Int 82:498
5. Silver J, Kilav R, Sela-Brown A, Naveh-Many T (2000) Molecular mechanisms of secondary hyperparathyroidism. Pediatr Nephrol 14:626–628
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献